Sky Century Investment (SKYI) Liabilities and Shareholders Equity (2013 - 2026)
Sky Century Investment (SKYI) posted quarterly Liabilities and Shareholders Equity of $128573.0 for Q2 2026, up 3.32% year-over-year from $124437.0 in Q2 2025, and up 18.41% quarter-over-quarter from $108586.0 in Q1 2026.
Sky Century Investment (SKYI) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Liabilities and Shareholders Equity for 5 consecutive years, with $128573.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 3.32% year-over-year to $128573.0; the TTM figure through May 2026 stood at $462424.0 (up 63.01% YoY), while the FY2025 annual figure was $111742.0, up 17.15% from the prior year.
- Liabilities and Shareholders Equity grew to $128573.0 in Q2 2026 per SKYI's latest filing, from $108586.0 in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $128573.0 in Q2 2026 and bottomed at $63858.0 in Q1 2025.
- Historically, Liabilities and Shareholders Equity has averaged $106586.1 across 3 years, with a median of $111742.0 in 2025.
- On a YoY basis, Liabilities and Shareholders Equity climbed as much as 70.04% in 2026 and fell as far as 3.32% in 2026.
- Sky Century Investment's Liabilities and Shareholders Equity stood at $95384.0 in 2024, then grew by 19.02% to $113523.0 in 2025, then gained by 13.26% to $128573.0 in 2026.
- Business Quant data shows SKYI's Liabilities and Shareholders Equity at $128573.0 in Q2 2026, $108586.0 in Q1 2026, and $113523.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 6.18 Bn |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 128,573.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 128,573.00 |
| Feb 28, 2026 | 108,586.00 |
| Nov 30, 2025 | 113,523.00 |
| Aug 31, 2025 | 111,742.00 |
| May 31, 2025 | 124,437.00 |
| Feb 28, 2025 | 63,858.00 |
| Aug 31, 2024 | 95,384.00 |
| Aug 31, 2014 | 515.00 |
| May 31, 2014 | 515.00 |
| Feb 28, 2014 | 515.00 |
| Nov 30, 2013 | 5,565.00 |
| Aug 31, 2013 | 479.00 |
| May 31, 2013 | 154.00 |